By c.angulo, 14 September, 2018 IGDRP agrees on a path forward and a new name - the International Pharmaceutical Regulators Programme (IPRP) for the consolidation of its operations with the International Pharmaceutical Regulators Forum (IPRF) The Steering Committee (SC) of the International Generic Drug Regulators Programme (IGDRP) met in Brasilia, Brazil on November 1-2, 2017. The Chair, A
By c.angulo, 14 September, 2018 IGDRP - 5th Meeting of the International Generic Drug Regulators Programme Members and Observers of the International Generic Drug Regulators Programme (IGDRP)participated in its 5th meeting which took place in Ottawa, Canada
By c.angulo, 14 September, 2018 IGDRP - 4th Meeting of the International Generic Drug Regulators Programme The Members of the International Generic Drug Regulators Programme (IGDRP) participated in its 4th meeting held in Mexico, from 17 to 20 October 2016.
By c.angulo, 14 September, 2018 IGDRP - 3rd Meeting of the International Generic Drug Regulators Programme The 3rd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Strasbourg, France, from 9-12 May 2016, the primary focus o
By c.angulo, 14 September, 2018 IGDRP - 2nd Meeting of the International Generic Drug Regulators Programme, Seoul, 4-5 November 2015 The 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Seoul, South Korea from 4-5 November 2015, with resolution
By c.angulo, 14 September, 2018 IGDRP - 1st Meeting of the International Generic Drug Regulators Programme The International Generic Drug Regulators Programme (IGDRP) was formed following progression from its 3-year Pilot phase and continues to promote coll
By c.angulo, 14 September, 2018 IGDRP - 2nd International Generic Drug Regulators Programme - Biowaivers Working Group - Public statement The Biowaivers Working Group held a face to face meeting on 2-3 November 2015 as part of the 2nd meeting of the International Generic Drug Regulators
By c.angulo, 14 September, 2018 IGDRP - 1st International Generic Drug Regulators Programme - Biowaivers Working Group - Public statement The IGDRP Biowaivers working group was formed in May 2013 with the objective of establishing a common set of conditions for the granting of biowaivers
By c.angulo, 14 September, 2018 IGDRP - 2nd International Generic Drug Regulators Programme – Active Substance Master File (ASMF)/Drug Master File (DMF) Working Group - Public statement With a view to improving international cooperation and work-sharing in the assessment of ASMF/DMF for generic drugs, the members of the ASMF/DMF Worki
By c.angulo, 14 September, 2018 IGDRP - 1st International Generic Drug Regulators Programme - ASMF/DMF Working Group - Public statement The IGDRP ASMF/DMF working group was formed in May 2013 to foster international collaboration and worksharing in the area of evaluations for ASMFs/DMF